Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

724
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
724
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

434
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
434
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

1.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.4K
Antigen Processing Pathways01:31

Antigen Processing Pathways

879
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
879
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

622
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
622
T Cell Types and Functions01:24

T Cell Types and Functions

756
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
756

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beta cell reactivity defines disease-relevant pancreatic CD8 T cells in type 1 diabetes.

bioRxiv : the preprint server for biology·2026
Same author

Coxsackievirus B escapes antiviral CD8<sup>+</sup> T cells but triggers robust CD4<sup>+</sup> memory responses.

Science advances·2026
Same author

Real-time in vivo analysis of murine β cells reveals autophagic flux defects before onset of autoimmune diabetes.

Science translational medicine·2026
Same author

From pancreas and islet resources to diabetes insights.

Diabetologia·2026
Same author

Type 1 diabetes screening: building a clinician-patient partnership for early care of chronic beta cell failure.

Diabetologia·2026
Same author

Characterisation of human pancreatic mesenchymal stromal cells in type 1 diabetes.

Diabetologia·2025

Related Experiment Video

Updated: May 23, 2025

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-&#945;
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

11.9K

Soluble HLA Class I Is Released From Human β-Cells Following Exposure to Interferons.

Pouria Akhbari1, Javier Perez-Hernandez2,3, Mark A Russell1

  • 1Islet Biology Exeter, Exeter Centre of Excellence for Diabetes Research, Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, U.K.

Diabetes
|March 10, 2025
PubMed
Summary

Human beta cells release soluble HLA class I (sHLA-I) when exposed to interferons. This finding suggests sHLA-I may influence inflammation in type 1 diabetes.

More Related Videos

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

9.7K
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

2.8K

Related Experiment Videos

Last Updated: May 23, 2025

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-&#945;
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

11.9K
Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

9.7K
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

2.8K

Area of Science:

  • Immunology
  • Endocrinology
  • Molecular Biology

Background:

  • HLA class I (HLA-I) molecules are crucial for immune surveillance by presenting peptides to CD8+ T cells.
  • Hyperexpression of HLA-I in pancreatic islets is a hallmark of type 1 diabetes, with a surrounding
  • Soluble forms of HLA-I (sHLA-I) are elevated in viral infections and autoimmune diseases, including type 1 diabetes.

Purpose of the Study:

  • To investigate whether human beta cells release soluble HLA class I (sHLA-I) in response to interferons.
  • To elucidate the mechanism of sHLA-I release from beta cells.
  • To explore the potential role of sHLA-I in type 1 diabetes pathogenesis.

Main Methods:

  • Treatment of human beta-cell lines and isolated human islets with interferon-α (IFN-α) and interferon-γ (IFN-γ).
  • Assessment of total, cell surface, and soluble HLA-I expression.
  • Analysis of HLA-I mRNA splice variants and extracellular vesicle content.

Main Results:

  • Interferon exposure significantly upregulated total and cell surface HLA-I in beta cells and islets.
  • Concomitant significant increase in soluble HLA-I (sHLA-I) release was observed.
  • sHLA-I release was primarily mediated by interferon-induced mRNA splice variants lacking the transmembrane domain, not extracellular vesicles or cleavage.

Conclusions:

  • Human beta cells respond to interferons by upregulating both cell-associated and soluble forms of HLA-I.
  • Soluble HLA-I is released from beta cells via mechanisms involving specific mRNA splice variants.
  • sHLA-I may play a role in modulating islet inflammation and CD8+ T cell activity during the autoimmune attack in type 1 diabetes.